Target intelligence / Profile preview

Ricin toxin A chain (RTA)

Target
RTA
Molecular classification
Enzyme, Ribosome-inactivating protein (Type 2 RIP), N-glycoside hydrolase, Toxin
01

Overview

Ricin toxin A chain is the protein subunit of ricin, a highly potent plant-derived toxin from Ricinus communis (castor bean plant)[3][5]. As part of a heterodimeric holotoxin (linked to the B chain via disulfide bond), the A chain is an N-glycoside hydrolase enzyme (approx. 32 kDa, 267 amino acids) that specifically depurinates adenine-4324 in the sarcin-ricin loop of eukaryotic 28S rRNA. This enzymatic lesion irreversibly blocks ribosomal function, thereby halting protein synthesis and rapidly killing affected cells[1][3][5][6]. Ricin toxin A chain is thus both a classic and highly effective ribosome-inactivating protein, responsible for the extreme toxicity of ricin holotoxin. There is significant interest in RTA as a biological warfare/terror agent, as well as a model for developing specific inhibitors and antidotes due to its unique mechanism of action[1][3][5][6].

Other names
Ricin A chainRicin A subunitRTARicin toxin A subunit
02

Mechanism of action

Inhibition of the N-glycosidase activity (hydrolysis of adenine in 28S rRNA)[2][4][6]. Small molecule inhibitors bind to the active site, impeding access to substrate rRNA[4][6]. Antibodies neutralize and block uptake or enzymatic activity.

03

Biological functions

Protein synthesis inhibitionInduction of cell death (cytotoxicity)Depurination of 28S rRNARibosome inactivation
04

Disease associations

Infection (bioterrorism/biological warfare agent)Other (toxin-mediated cytotoxicity)
05

Safety considerations

Extreme cytotoxicity, even at very low doses[3][5]Potential for use as a bioweapon/bioterrorism threat[3][5]Lack of approved antidote for human exposureRisk of severe organ damage upon exposure
06

Interacting drugs

N-(pterin-7-carbonyl)glycyl-L-tyrosine (7PCGY)[4][6]

2 more in the full profile.

07

Biomarkers

Detection of depurinated 28S rRNARicin-specific antibody titers (for exposure/immune response monitoring)Cellular protein synthesis inhibition markers

Beyond the preview

Go deeper on Ricin toxin A chain (RTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ricin toxin A chain (RTA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call